Internal Medicine, Hematology & Oncology · Hazard, KY
NPI
1114180080
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
200 Medical Center Dr
Hazard, KY, 41701
Phone (606) 487-7902
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
968 services
Medicare patients, 2024
269
Average age 72
Drug cost, 2024
$13.0M
3,918 prescriptions
Company payments, 2025
$1,784
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel D Bailey was code 99214 (office e&m - established), 410 times for 172 patients. In total Samuel D Bailey billed 968 services in 16 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 410 | 172 | $53.25 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 136 | 98 | $12.67 | $1,723 |
| 99213 Office E&M - Established | Facility | 106 | 79 | $31.23 | $3,310 |
| 99231 Hospital E&M - Subsequent | Facility | 95 | 35 | $37.87 | $3,597 |
| 99232 Hospital E&M - Subsequent | Facility | 49 | 23 | $60.55 | $2,967 |
| 99215 Office E&M - Established | Facility | 42 | 31 | $74.25 | $3,119 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Facility | 35 | 13 | $73.64 | $2,577 |
| 99221 Hospital E&M - Initial | Facility | 31 | 26 | $64.59 | $2,002 |
| 99205 Office E&M - New | Facility | 26 | 26 | $120.25 | $3,127 |
| 99222 Hospital E&M - Initial | Facility | 19 | 18 | $102.12 | $1,940 |
| 99204 Office E&M - New | Facility | 12 | 12 | $100.50 | $1,206 |
By year: 2022 $46K for 854 services; 2023 $45K for 842 services; 2024 $48K for 968 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samuel D Bailey prescribed most often to Medicare patients was Letrozole, with 269 prescriptions and refills. In total Samuel D Bailey wrote 3,918 Medicare prescriptions that cost $13.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 269 | 379 | 48 | $3,015 |
| Oxycodone Hcl Generic | 258 | 258 | 53 | $11K |
| Gabapentin Generic | 205 | 205 | 40 | $1,385 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 196 | 196 | 44 | $4,971 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 176 | 176 | 57 | $3,124 |
| Ondansetron Hcl Generic | 161 | 162 | 79 | $32K |
| Prochlorperazine Maleate Generic | 148 | 148 | 73 | $2,608 |
| Keytruda Pembrolizumab | 98 | 98 | 12 | $1.1M |
| Clonazepam Generic | 90 | 91 | 13 | $269 |
| Prednisone Generic | 83 | 85 | 34 | $413 |
| Pregabalin Generic | 52 | 52 | Under 11 | $596 |
| Exemestane Generic | 51 | 65 | 12 | $5,619 |
| Morphine Sulfate Er Morphine Sulfate | 47 | 47 | 14 | $1,575 |
| Imfinzi Durvalumab | 45 | 45 | Under 11 | $426K |
| Fentanyl Generic | 45 | 45 | Under 11 | $5,291 |
Brand drugs: - claims; generic drugs: 2,741 claims; opioid claims: 762.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel D Bailey $1,784 ($1,784 in general payments such as food, travel and fees) from 36 companies. The largest payer was Novartis Pharmaceuticals Corporation with $205.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 12 | $205 |
| Abbvie Inc. ABBV | 8 | $145 |
| Janssen Biotech, Inc. JNJ | 6 | $125 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $114 |
| Pfizer Inc. PFE | 5 | $93.88 |
| Daiichi Sankyo Inc. 4568.T | 4 | $89.13 |
| Merck Sharp & Dohme LLC MRK | 4 | $81.62 |
| PharmaEssentia USA Corporation 6446.TW | 3 | $81.06 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $71.15 |
| Aveo Pharmaceuticals, Inc. | 4 | $68.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.